Neurosearch denies share manipulation charges

COPENHAGEN Wed May 23, 2012 3:24pm IST

Related Topics

Stocks

   
Rajalakshmi (C), 28, smiles after winning the Miss Wheelchair India beauty pageant in Mumbai November 26, 2014. REUTERS/Danish Siddiqui

Miss Wheelchair India

Seven women from across India participated in the country's second wheelchair beauty pageant, which aims to open doors for the wheelchair-bound in modelling, film and television, according to organisers  Slideshow 

COPENHAGEN (Reuters) - Danish biopharma firm Neurosearch A/S said on Wednesday charges of share price manipulation had been filed against it, but it denied the allegations and said it was working with the authorities to clear up the matter.

Neurosearch said the charges were related to an announcement in February 2010 in which the management of the company reported top-line results from a Phase III study with its Huntington's disease drug candidate Huntexil and then two months later reassessed and corrected the data in a new announcement.

"On the present basis, Neurosearch is denying the charges and is collaborating fully with the authorities in order to resolve the matter," the company said in a statement.

(Reporting by John Acher)

FILED UNDER:

Ebola Outbreak

Reuters Showcase

Ebola Crisis

Ebola Crisis

U.N. to miss Dec 1 Ebola target due to rising Sierra Leone cases.  Full Article 

Tobacco Curbs

Tobacco Curbs

China considers tougher tobacco controls: Xinhua.  Full Article 

Reuters Exclusive

Reuters Exclusive

Pay per puff? Caffeine stick? E-cigarette boom sparks race for new patents  Full Article 

Healthy Diet

Healthy Diet

Studies examine U.S. meals in schools.  Full Article 

Fatal Accidents

Fatal Accidents

Helmets, engine size important in child deaths on ATVs.  Full Article 

Fertility Woes

Fertility Woes

Little understood chemicals cut men’s fertility.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage